We are monitoring the impact of COVID-19 on Europe Insulin Delivery Devices Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 228
Share on
Share on

European Insulin Delivery Devices Market Analysis - By Type, Application, Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) – Industry Analysis on Size, Share, Trends, Growth, Forecast | 2019 - 2024

Pulished: August, 2019
ID: 228
Pages: 138

Europe Insulin Delivery Devices Market Size & Growth Rate (2019 - 2024)

As per our report, the size of the insulin delivery devices market in Europe is estimated to value USD 4.26 billion by 2024 from USD 3.12 billion in 2019, registering a growth rate of 6.40% from 2019 to 2024.

Europe Insulin maintains sugar levels in the blood and essential for the people suffering from type I diabetes & type II diabetes. The development of insulin delivery devices has been encouraged in the past years. These devices are used to deliver insulin doses via the parenteral route rather than oral route of administration. Insulin delivery devices promote the absorption rate of insulin into the bloodstream from the site of injection to execute immediate pharmacological action of insulin. Some of the majorly used insulin delivery devices such as insulin syringes, insulin pens, insulin pen needles, insulin pumps, and insulin jet injectors.

Presence of favorable medical reimbursements for human insulin pens across Europe, increasing funding for the research, increasing adoption of organic growth strategies by market players and growing diabetic patient awareness towards the benefits of insulin delivery devices in diabetes treatment are driving the growth of insulin delivery devices market Europe.

However, the requirement of extensive procedures for the approval of devices and limited accessibility of insulin delivery devices in certain areas of Europe are expected to restrain the growth of the insulin delivery devices market in Europe.

This research report segmented and sub-segmented into the following categories:

  • By Type: Insulin Syringes, Insulin Pens, Insulin Pen Needles, Insulin Pumps And Insulin Jet Injectors
  • By Application: Type I Diabetes, Type II Diabetes
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

On the basis of type, the insulin syringes segment commanded the largest share of Europe insulin delivery devices market in 2019, whereas insulin pens segment is estimated to grow at the highest CAGR during the forecast period 2019-2024.

On the basis of region, Europe's insulin delivery devices market is segmented as U.K., Germany, France, Italy, and Spain.

Key players operating in the Europe Insulin Delivery Devices Market profiled in this report are  Becton, Dickinson, and Company (U.S.), Sanofi (France), Novo Nordisk A/S (Denmark), Julphar (U.A.E.), Eli Lilly and Company (U.S.), Biocon Ltd. (India), Ypsomed AG (Switzerland), Wockhardt Ltd. (India), B. Braun Meselgen AG (Switzerland) and Biodel Inc. (U.S.).

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Introduction                                                               

                5.2 Type                                                              

                                5.2.1 Introduction                                           

                                5.2.2 Insulin Syringes                                     

                                5.2.3 Insulin Pens                                            

                                5.2.4 Insulin Pen Needles                                            

                                5.2.5 Insulin Pumps                                        

                                5.2.6 Insulin Jet Injectors                                             

                5.3 Application                                                 

                                5.3.1 Introduction                                           

                                5.3.2 Type I Diabetes                                     

                                5.3.3 Type II Diabetes                                    

6. Geographical Analysis                                                                              

                                6.2.1 Introduction                                           

                                6.2.2 U.K                                             

                                6.2.3 Spain                                         

                                6.2.4 Germany                                 

                                6.2.5 Italy                                            

                                6.2.6 France                                       

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Sanofi (France)                                                         

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Novo Nordisk A/S (Denmark)                                                             

                8.3 Eli Lilly and Company (U.S.)                                                  

                8.4 Biocon Ltd. (India)                                                   

                8.5 Julphar (U.A.E.)                                                        

                8.6 Ypsomed AG (Switzerland)                                                  

                8.7 Becton, Dickinson and Company (U.S.)                                                          

                8.8 Wockhardt Ltd. (India)                                                           

                8.9 B. Braun Meselgen AG (Switzerland)                                                              

                8.10 Biodel Inc. (U.S.)                                                    

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Expert Opinions                                                                        

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Insulin Delivery Devices Market By Region, From 2019-2024 (USD Billion)
  2. Europe Insulin Delivery Devices Market By Type, From 2019-2024 (USD Billion)
  3. Europe Insulin Syringes Market By Region, From 2019-2024 (USD Billion)
  4. Europe Insulin Pens Market By Region, From 2019-2024 (USD Billion)
  5. Europe Insulin Pen Needles Market By Region, From 2019-2024 (USD Billion)
  6. Europe Insulin Pumps Market By Region, From 2019-2024 (USD Billion)
  7. Europe Insulin Jet Injectors Market By Region, From 2019-2024 (USD Billion)
  8. Europe Insulin Delivery Devices Market By Application, From 2019-2024 (USD Billion)
  9. Europe Type I Diabetes of Insulin Delivery Devices Market By Region, From 2019-2024 (USD Billion)
  10. Europe Type II Diabetes of Insulin Delivery Devices Market By Region, From 2019-2024 (USD Billion)
  11. U.K Insulin Delivery Devices Market By Type, From 2019-2024 (USD Billion)
  12. U.K Insulin Delivery Devices Market By Application, From 2019-2024 (USD Billion)
  13. Spain Insulin Delivery Devices Market By Type, From 2019-2024 (USD Billion)
  14. Spain Insulin Delivery Devices Market By Application, From 2019-2024 (USD Billion)
  15. Germany Insulin Delivery Devices Market By Type, From 2019-2024 (USD Billion)
  16. Germany Insulin Delivery Devices Market By Application, From 2019-2024 (USD Billion)
  17. Italy Insulin Delivery Devices Market By Type, From 2019-2024 (USD Billion)
  18. Italy Insulin Delivery Devices Market By Application, From 2019-2024 (USD Billion)
  19. France Insulin Delivery Devices Market By Type, From 2019-2024 (USD Billion)
  20. France Insulin Delivery Devices Market By Application, From 2019-2024 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample